Journal of Clinical Endocrinology & Metabolism, Vol 53, 69-75, Copyright © 1981 by Endocrine Society

ARTICLES

Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma

MM Pugeat, JF Dunn and BC Nisula

This report describes the binding of 70 synthetic compounds to both testosterone-binding globulin (TeBG) and corticosteroid-binding globulin (CBG). The ability of each compound to displace [3H]testosterone from TeBG and [3H]cortisol from CBG adsorbed from a plasma pool onto a solid phase matrix of Concanavalin A-Sepharose was determined under equilibrium conditions at physiological pH and temperature. From these data, the association constants of the compounds for binding to both TeBG and CBG were calculated and used to predict whether endogenous steroid transport would be altered by the therapeutic administration of the drug. Computer simulation predicted that by interacting with TeBG, therapeutic levels of danazol, methyltestosterone, fluoxymesterone, and norgestrel could displace 83%, 48%, 43%, and 16%, respectively, of the concentration of testosterone bound to TeBG in a normal man. Similarly, by interacting with CBG, therapeutic levels of prednisolone could decrease the concentration of cortisol bound to CBG by approximately 32% in both men and women, and despite relatively low affinity binding to TeBG (5 X 10(5) M-1), prednisolone could also displace small amounts of testosterone from TeBG. These results indicate that binding to steroid transport proteins should be considered among the in vivo effects of drugs on endogenous steroid hormone levels.

This article has been cited by other articles:

				M. N. Samtani, N. A. Pyszczynski, D. C. DuBois, R. R. Almon, and W. J. Jusko Modeling Glucocorticoid-Mediated Fetal Lung Maturation: I. Temporal Patterns of Corticosteroids in Rat Pregnancy J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 117 - 126. [Abstract] [Full Text] [PDF]

				F. Giton, J. Fiet, J. Guechot, F. Ibrahim, F. Bronsard, D. Chopin, and J.-P. Raynaud Serum Bioavailable Testosterone: Assayed or Calculated? Clin. Chem., March 1, 2006; 52(3): 474 - 481. [Abstract] [Full Text] [PDF]

				J. Taieb, B. Mathian, F. Millot, M.-C. Patricot, E. Mathieu, N. Queyrel, I. Lacroix, C. Somma-Delpero, and P. Boudou Testosterone Measured by 10 Immunoassays and by Isotope-Dilution Gas Chromatography-Mass Spectrometry in Sera from 116 Men, Women, and Children Clin. Chem., August 1, 2003; 49(8): 1381 - 1395. [Abstract] [Full Text] [PDF]

				M. C. Meriggiola, T. M.M. Farley, and M. T. Mbizvo A Review of Androgen-Progestin Regimens for Male Contraception J Androl, July 1, 2003; 24(4): 466 - 483. [Full Text] [PDF]

				I. Grishkovskaya, G. V. Avvakumov, G. L. Hammond, M. G. Catalano, and Y. A. Muller Steroid Ligands Bind Human Sex Hormone-binding Globulin in Specific Orientations and Produce Distinct Changes in Protein Conformation J. Biol. Chem., August 23, 2002; 277(35): 32086 - 32093. [Abstract] [Full Text] [PDF]

				M. Fleshner, T. Deak, K. T. Nguyen, L. R. Watkins, and S. F. Maier Endogenous Glucocorticoids Play a Positive Regulatory Role in the Anti-Keyhole Limpet Hemocyanin In Vivo Antibody Response J. Immunol., March 15, 2001; 166(6): 3813 - 3819. [Abstract] [Full Text] [PDF]

				A. Louw and P. Swart Salsola tuberculatiformis Botschantzev and an Aziridine Precursor Analog Mediate the in Vivo Increase in Free Corticosterone and Decrease in Corticosteroid-Binding Globulin in Female Wistar Rats Endocrinology, May 1, 1999; 140(5): 2044 - 2053. [Abstract] [Full Text]

				C. Tsigos, I. Kyrou, G. P. Chrousos, and D. A. Papanicolaou Prolonged Suppression of Corticosteroid-Binding Globulin by Recombinant Human Interleukin-6 in Man J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3379 - 3379. [Full Text]